Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer.

导出 OA

翻译打印收藏纠错

作者： M,Ando ^[1] ; K,Eguchi ; T,Shinkai ; T,Tamura ; Y,Ohe ; N,Yamamoto ; T,Kurata ; T,Kasai ; H,Ohmatsu ; K,Kubota ; I,Sekine ; N,Hojo ; T,Matsumoto ; T,Kodama ; R,Kakinuma ; Y,Nishiwaki ; N,Saijo

作者单位： The Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. ^[1]

主题词成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);喜树碱(Camptothecin);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);用药计划表(Drug Administration Schedule);酶抑制剂(Enzyme Inhibitors);依托泊甙(Etoposide);女(雌)性(Female);血液病(Hematologic Diseases);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);拓扑异构酶I抑制剂(Topoisomerase I Inhibitors);拓扑异构酶II抑制剂(Topoisomerase II Inhibitors)

DOI 10.1038/bjc.1997.584

PMID 9400948

发布时间 2019-05-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览16

British journal of cancer

1997年76卷11期

1494-9页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer.

British journal of cancer

相似文献

British journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer.

British journal of cancer

相似文献

British journal of cancer

相关期刊

检索历史清除